Her2/neu-positive disease does not increase risk of locoregional recurrence for patients treated with neoadjuvant doxorubicin-based chemotherapy, mastectomy, and radiotherapy

Thomas A. Buchholz, Eugene H. Huang, Donald Berry, Lajos Pusztai, Eric A. Strom, Marsha D. McNeese, George H. Perkins, Naomi R. Schechter, Henry M. Kuerer, Aman U. Buzdar, Vicente Valero, Kelly K. Hunt, Gabriel N. Hortobagyi, Aysegul A. Sahin

Research output: Contribution to journal › Article › peer-review

28 Scopus citations

Fingerprint

Dive into the research topics of 'Her2/neu-positive disease does not increase risk of locoregional recurrence for patients treated with neoadjuvant doxorubicin-based chemotherapy, mastectomy, and radiotherapy'. Together they form a unique fingerprint.

Physics & Astronomy

Medicine & Life Sciences